XML 34 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 21,855 $ 23,181
Adjustments to reconcile net income to cash flows provided by (used in) operating activities:    
Depreciation and amortization 3,548 3,661
Operating (gains), losses and other charges, net 0 532
Gains and amortization on interest rate swap derivatives, net (20,253) (29,733)
Amortization of deferred financing costs 158 344
Losses on investments 65 8
Losses on early termination of debt and leases 24 34
Deferred income tax expense 4,436 4,099
Share-based compensation expense 4,015 3,472
Changes in assets and liabilities:    
Receivables (3,567) 353
Inventories (4,768) 13
Prepaids and other current assets 3,451 5,294
Other noncurrent assets 4,085 (201)
Operating lease assets and liabilities (244) (604)
Accounts payable (2,405) 1,820
Accrued payroll (7,475) (1,704)
Accrued taxes (1) (380)
Other accrued liabilities (7,488) 1,195
Other noncurrent liabilities (2,500) (1,149)
Net cash flows provided by (used in) operating activities (7,064) 10,235
Cash flows from investing activities:    
Capital expenditures (2,778) (1,583)
Proceeds from sales of restaurants, real estate and other assets 108 1,348
Investment purchases (1,200) 0
Proceeds from sale of investments 0 200
Collections on notes receivable 67 215
Net cash flows provided by (used in) investing activities (3,803) 180
Cash flows from financing activities:    
Revolver borrowings 13,825 7,500
Revolver payments (12,325) (2,500)
Long-term debt payments (503) (473)
Proceeds from exercise of stock options 0 116
Tax withholding on share-based payments (2,165) (1,309)
Deferred financing costs 0 (8)
Purchase of treasury stock (12,498) 0
Net bank overdrafts 0 (3,125)
Net cash flows provided by (used in) financing activities (13,666) 201
Increase (decrease) in cash and cash equivalents (24,533) 10,616
Cash and cash equivalents at beginning of period 30,624 3,892
Cash and cash equivalents at end of period $ 6,091 $ 14,508